Medicare Enrolled

Dr. Shahul Riazudeen, MD

Internal Medicine · Wimauma, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
16541 S US HIGHWAY 301, Wimauma, FL 33598
8136331100
In practice since 2006 (19 years)
NPI: 1932163888 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Riazudeen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Riazudeen? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Riazudeen

Dr. Shahul Riazudeen is an internal medicine in Wimauma, FL, with 19 years in practice. Based on federal Medicare data, Dr. Riazudeen performed 10,662 Medicare services across 4,354 unique beneficiaries.

Between the years covered by Open Payments, Dr. Riazudeen received a total of $4,519 from 46 pharmaceutical and/or device companies across 236 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Riazudeen is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 3% volume in FL$ $4,519 industry payments

Medicare Practice Summary

Medicare Utilization ↗
10,662
Medicare services
Top 3% in FL for internal medicine
4,354
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~561 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)2,520$18$27
Office visit, established patient (30-39 min)2,268$93$151
Office visit, established patient (20-29 min)1,747$67$101
Hospital follow-up visit, moderate complexity747$64$119
Annual wellness visit, follow-up515$129$158
Annual depression screening505$18$34
Flu vaccine administration228$30$38
Flu vaccine, quadrivalent227$76$95
Initial hospital admission, moderate complexity217$106$214
Hospital discharge day management, 30 minutes or less154$65$120
Drug injection, under skin or into muscle122$10$38
Urinalysis, manual113$3$38
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg111$1$6
Hospital discharge management, 30+ min105$93$176
Transitional care management services for problem of at least moderate complexity90$158$206
Steroid injection (triamcinolone)87$1$8
Transitional care management services for problem of high complexity81$219$291
Electrocardiogram (EKG), 12-lead69$11$63
Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use65$282$300
New patient office visit (45-59 min)64$118$227
Hospital follow-up visit, high complexity63$96$170
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and62$41$101
Pneumonia vaccine administration61$30$38
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional53$17$38
Office visit, established patient (10-19 min)49$38$63
Initial hospital admission, high complexity44$140$302
Nursing facility visit, low complexity43$58$113
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle42$56$95
Annual alcohol misuse screening, 5 to 15 minutes41$18$34
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a38$30$82
Office visit, established patient, complex (40-54 min)34$135$195
Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes30$107$221
Nursing facility visit, moderate complexity26$76$151
New patient office visit (30-44 min)15$55$151
New patient office visit, complex (60-74 min)15$153$284
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit11$165$227
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,519
Total received (2018-2024)
Avg $646/year across 7 years
Top 15% in FL for internal medicine
46
Companies
236
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,505 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$630
2023
$718
2022
$913
2021
$1,068
2020
$372
2019
$570
2018
$247

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$551
Janssen Pharmaceuticals, Inc
$405
Amgen Inc.
$353
ABBVIE INC.
$225
Novo Nordisk Inc
$220
Abbott Laboratories
$218
PFIZER INC.
$176
Biogen, Inc.
$164
Amarin Pharma Inc.
$161
AstraZeneca Pharmaceuticals LP
$142
Lundbeck LLC
$122
Sunovion Pharmaceuticals Inc.
$118
Bayer HealthCare Pharmaceuticals Inc.
$106
GlaxoSmithKline, LLC.
$100
Kowa Pharmaceuticals America, Inc.
$96
Merck Sharp & Dohme LLC
$94
Exact Sciences Corporation
$87
Boehringer Ingelheim Pharmaceuticals, Inc.
$82
Sumitomo Pharma America, Inc.
$79
Otsuka America Pharmaceutical, Inc.
$77
Avanir Pharmaceuticals, Inc.
$71
Dexcom, Inc.
$71
Gilead Sciences, Inc.
$71
AbbVie Inc.
$65
Astellas Pharma US Inc
$60
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$57
Novartis Pharmaceuticals Corporation
$48
Medtronic, Inc.
$44
Boston Scientific Corporation
$41
Merck Sharp & Dohme Corporation
$41
Esperion Therapeutics, Inc.
$41
Alexion Pharmaceuticals, Inc.
$39
Supernus Pharmaceuticals, Inc.
$33
Medtronic USA, Inc.
$29
Bayer Healthcare Pharmaceuticals Inc.
$25
Axsome Therapeutics, Inc.
$24
Recor Medical Inc
$24
OPKO Pharmaceuticals, LLC
$23
DEXCOM, INC.
$23
Philips North America LLC
$22
Inspire Medical Systems, Inc.
$21
IDORSIA PHARMACEUTICALS US INC
$18
Lucid Diagnostics Inc.
$16
Allergan, Inc.
$14
E.R. Squibb & Sons, L.L.C.
$12
Noden Pharma USA Inc
$11
Top 3 companies account for 29.0% of total payments
Associated products mentioned in payments ›
(CK7) Extended Holter · ADUHELM · AIRSUPRA · AMYVID · ANORO ELLIPTA · Aimovig · BASAGLAR · BELSOMRA · BREZTRI · CHANTIX · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Epclusa · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · GEMTESA · INSPIRE · INTELLIS · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LINZESS · LONHALA MAGNAIR · Livalo · MOUNJARO · MitraClip System · Myrbetriq · NEXLETOL · NUEDEXTA · Nuedexta · Otezla · Ozempic · PARADISE RENAL DENERVATION SYSTEM · PAXLOVID · Proclaim Family of SCS IPGs · Proclaim IPG · Prolia · QUVIVIQ · RAYALDEE · REXULTI · RYBELSUS · Rybelsus · SEGLENTIS · SHINGRIX · SYNTHROID · Strensiq · Sunosi · TEKTURNA · TRADJENTA · TRELEGY ELLIPTA · TROKENDI XR · TRULICITY · Tresiba · UBRELVY · VENCLEXTA · VERQUVO · VESICARE · VRAYLAR · Vascepa · Veozah · Victoza · WATCHMAN · WATCHMAN FLX · XARELTO · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $42 per 100 Medicare services performed
Looking for a internal medicine in Wimauma?
Compare internal medicines in the Wimauma area by procedure volume, costs, and industry payment transparency.
Browse internal medicines nearby

Geographic Context

Internal Medicines within 10 mi
836
Per 100K population
56.1
County median income
$75,011
Nearest hospital
HCA FLORIDA SOUTH SHORE HOSPITAL
5.1 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Riazudeen is a clinical cardiology specialist, with above-average Medicare volume (top 3% in FL), and high industry engagement (low-engagement, top 15%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Riazudeen experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Riazudeen performed 2,520 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Riazudeen receive payments from pharmaceutical companies?
Yes. Dr. Riazudeen received a total of $4,519 from 46 companies across 236 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Riazudeen's costs compare to other internal medicines in Wimauma?
Dr. Riazudeen's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Riazudeen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →